STRATA Skin Sciences (NASDAQ:SSKN) was downgraded by equities researchers at TheStreet from a “c-” rating to a “d” rating in a research note issued to investors on Thursday, TheStreetRatingsTable reports.
Separately, Zacks Investment Research upgraded shares of STRATA Skin Sciences from a “sell” rating to a “hold” rating in a report on Wednesday, August 18th.
NASDAQ SSKN opened at $1.44 on Thursday. STRATA Skin Sciences has a 52-week low of $1.30 and a 52-week high of $2.84. The company has a 50-day simple moving average of $1.72 and a 200 day simple moving average of $1.58. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.38 and a current ratio of 1.65. The company has a market capitalization of $49.49 million, a PE ratio of -20.57 and a beta of 2.17.
STRATA Skin Sciences (NASDAQ:SSKN) last posted its quarterly earnings data on Wednesday, November 10th. The medical device company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.03. STRATA Skin Sciences had a negative net margin of 8.32% and a negative return on equity of 16.97%. During the same quarter in the prior year, the firm earned ($0.04) earnings per share. As a group, analysts forecast that STRATA Skin Sciences will post -0.14 EPS for the current fiscal year.
Several institutional investors and hedge funds have recently bought and sold shares of the company. Cannell Capital LLC increased its stake in shares of STRATA Skin Sciences by 1.6% in the third quarter. Cannell Capital LLC now owns 874,321 shares of the medical device company’s stock worth $1,609,000 after purchasing an additional 13,496 shares in the last quarter. Western Standard LLC purchased a new position in shares of STRATA Skin Sciences in the third quarter worth about $875,000. 22NW LP purchased a new position in shares of STRATA Skin Sciences in the second quarter worth about $2,299,000. Finally, Vanguard Group Inc. boosted its position in shares of STRATA Skin Sciences by 8.1% in the second quarter. Vanguard Group Inc. now owns 799,614 shares of the medical device company’s stock valued at $1,248,000 after acquiring an additional 60,057 shares during the period. Hedge funds and other institutional investors own 27.79% of the company’s stock.
About STRATA Skin Sciences
STRATA Skin Sciences, Inc is a medical technology company in Dermatology and Plastic Surgery. It engages in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through the following segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment.